Category: Clinical Breakthroughs

  • Groundbreaking Findings for Patients with Cystic Fibrosis

    Groundbreaking Findings for Patients with Cystic Fibrosis

    Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to results from a Northwestern Medicine clinical trial.